Inferring clonal structure in HTLV-1-infected individuals: towards bridging the gap between analysis and visualization

BackgroundHuman T cell leukemia virus type 1 (HTLV-1) causes adult T cell leukemia (ATL) in a proportion of infected individuals after a long latency period. Development of ATL is a multistep clonal process that can be investigated by monitoring the clonal expansion of HTLV-1-infected cells by isolation of provirus integration sites. The clonal composition (size, number, and combinations of clones) during the latency period in a given infected individual has not been clearly elucidated.MethodsWe used high-throughput sequencing technology coupled with a tag system for isolating integration sites and measuring clone sizes from 60 clinical samples. We assessed the role of clonality and clone size dynamics in ATL onset by modeling data from high-throughput monitoring of HTLV-1 integration sites using single- and multiple-time-point samples.ResultsFrom four size categories analyzed, we found that big clones (B; 513–2048 infected cells) and very big clones (VB; >2048 infected cells) had prognostic value. No sample harbored two or more VB clones or three or more B clones. We examined the role of clone size, clone combination, and the number of integration sites in the prognosis of infected individuals. We found a moderate reverse correlation between the total number of clones and the size of the largest clone. We devised a data-driven model that allows intuitive representation of clonal composition.ConclusionsThis integration site-based clonality tree model represents the complexity of clonality and provides a global view of clonality data that facilitates the analysis, interpretation, understanding, and visualization of the behavior of clones on inter- and intra-individual scales. It is fully data-driven, intuitively depicts the clonality patterns of HTLV-1-infected individuals and can assist in early risk assessment of ATL onset by reflecting the prognosis of infected individuals. This model should assist in assimilating information on clonal composition and understanding clonal expansion in HTLV-1-infected individuals.

[1]  D. Laydon,et al.  Genome-wide Determinants of Proviral Targeting, Clonal Abundance and Expression in Natural HTLV-1 Infection , 2013, PLoS pathogens.

[2]  Andrew D Higginson,et al.  Heavy use of equations impedes communication among biologists , 2012, Proceedings of the National Academy of Sciences.

[3]  R. Gallo.  The discovery of the first human retrovirus: HTLV-1 and HTLV-2 , 2005, Retrovirology.

[4]  S. Wain-Hobson,et al.  Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy , 1995, Journal of virology.

[5]  F. Bushman,et al.  The host genomic environment of the provirus determines the abundance of HTLV-1–infected T-cell clones , 2011, Blood.

[6]  Xuezhi Li,et al.  Global dynamics of a mathematical model for HTLV-I infection of CD4+ T-cells☆ , 2011 .

[7]  K. Ohshima,et al.  Clonal integration and expression of human T‐cell lymphotropic virus type I in carriers detected by polymerase chain reaction and inverse PCR , 1997, American journal of hematology.

[8]  Kenta Nakai,et al.  Clonality of HTLV-1-infected T cells as a risk indicator for development and progression of adult T-cell leukemia. , 2017, Blood advances.

[9]  S. Wain-Hobson,et al.  Stochastic events in the amplification of HTLV-I integration sites by linker-mediated PCR. , 1995, Research in virology.

[10]  K. Yamaguchi,et al.  Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Daniel J. Laydon,et al.  Quantification of HTLV-1 Clonality and TCR Diversity , 2014, PLoS Comput. Biol..

[12]  M. Matsuoka,et al.  A novel diagnostic method of adult T-cell leukemia: monoclonal integration of human T-cell lymphotropic virus type I provirus DNA detected by inverse polymerase chain reaction. , 1994, Blood.

[13]  C. Maley,et al.  Cancer is a disease of clonal evolution within the body1–3. This has profound clinical implications for neoplastic progression, cancer prevention and cancer therapy. Although the idea of cancer as an evolutionary problem , 2006 .

[14]  Yosvany López,et al.  Development and validation of a new high-throughput method to investigate the clonality of HTLV-1-infected cells based on provirus integration sites , 2014, Genome Medicine.

[15]  K. Yamaguchi,et al.  Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. , 2010, Blood.

[16]  M. Matsuoka,et al.  Role of HTLV‐1 proviral DNA load and clonality in the development of adult T‐cell leukemia/lymphoma in asymptomatic carriers , 2004, International journal of cancer.

[17]  M. Shimoyama,et al.  Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma , 1991, British journal of haematology.

[18]  Toshiki Watanabe.  Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells. , 2017, Blood.

[19]  Mel Greaves,et al.  Evolutionary determinants of cancer. , 2015, Cancer discovery.

[20]  Georgios A. Pavlopoulos,et al.  A reference guide for tree analysis and visualization , 2010, BioData Mining.

[21]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[22]  J. Seydel,et al.  Modeling the T-cell dynamics and pathogenesis of HTLV-I infection , 1999, Bulletin of mathematical biology.

[23]  Carlo C. Maley,et al.  Cancer in Light of Experimental Evolution , 2012, Current Biology.

[24]  K. Nakano,et al.  Transition of adult T-cell leukemia/lymphoma clones during clinical progression , 2016, International journal of hematology.

[25]  K. Yamaguchi,et al.  Human T lymphotropic virus type-I and adult T-cell leukemia in Japan , 2002, International journal of hematology.

[26]  P. Nowell.  The clonal evolution of tumor cell populations. , 1976, Science.

[27]  Denise Kirschner,et al.  Mathematical analysis of the global dynamics of a model for HTLV-I infection and ATL progression. , 2002, Mathematical biosciences.

[28]  M. Tomonaga,et al.  Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease. , 1997, Blood.

[29]  M. Nowak,et al.  Population Dynamics of Immune Responses to Persistent Viruses , 1996, Science.

[30]  K. Yamaguchi,et al.  Adult T-Cell Leukemia: A Review of Epidemiological Evidence , 2012, Front. Microbio..

[31]  Ralph P. Grimaldi,et al.  Discrete and Combinatorial Mathematics: An Applied Introduction , 1998 .

[32]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[33]  Kyle Summers,et al.  Evolutionary biology of cancer. , 2005, Trends in ecology & evolution.

[34]  Edwin Wang,et al.  Cancer modeling and network biology: accelerating toward personalized medicine. , 2015, Seminars in cancer biology.

[35]  Shigui Ruan,et al.  Dynamics of human T-cell lymphotropic virus I (HTLV-I) infection of CD4+ T-cells. , 2004, Comptes rendus biologies.

[36]  Jeremy Gunawardena,et al.  Models in biology: ‘accurate descriptions of our pathetic thinking’ , 2014, BMC Biology.

[37]  K. Ishitsuka,et al.  Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. , 2014, The Lancet. Oncology.

[38]  C. Bangham,et al.  HTLV-1-infected T cells contain a single integrated provirus in natural infection. , 2012, Blood.

[39]  M. Matsuoka,et al.  Natural history of adult T-cell leukemia/lymphoma and approaches to therapy , 2005, Oncogene.

[40]  S. Wain-Hobson,et al.  Proliferation of HTLV-1 infected circulating cells in vivo in all asymptomatic carriers and patients with TSP/HAM. , 1996, Oncogene.

[41]  F. Michor,et al.  Improving Cancer Treatment via Mathematical Modeling: Surmounting the Challenges Is Worth the Effort , 2015, Cell.

[42]  R. Chambers,et al.  The role of mathematical modeling in medical research: "research without patients?". , 2000, The Ochsner journal.

[43]  Y. Nagata,et al.  HTLV-I transmission from mother to child. , 2000, Journal of reproductive immunology.

[44]  F. Markowetz,et al.  Cancer Evolution: Mathematical Models and Computational Inference , 2014, Systematic biology.

[45]  O. Wolkenhauer.  Why model? , 2013, Front. Physiol..

[46]  P. Maini,et al.  HTLV-I infection: a dynamic struggle between viral persistence and host immunity. , 2014, Journal of theoretical biology.

[47]  G. Fusco.  For a new dialogue between theoretical and empirical studies in evo-devo , 2015, Front. Ecol. Evol..

[48]  Steve Goodison,et al.  Cancer progression modeling using static sample data , 2014, Genome Biology.

[49]  S. Wain-Hobson,et al.  Adult T-cell leukemia/lymphoma on a background of clonally expanding human T-cell leukemia virus type-1-positive cells. , 1996, Blood.

[50]  C. Bangham,et al.  HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection , 2014, Seminars in cancer biology.

[51]  S. Kamihira,et al.  Significance of HTLV-1 proviral load quantification by real-time PCR as a surrogate marker for HTLV-1-infected cell count. , 2003, Clinical and laboratory haematology.

[52]  M. Matsuoka,et al.  Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. , 1997, Cancer research.

[53]  Anat Melamed,et al.  The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphoma. , 2014, Blood.

[54]  K. Nakai,et al.  Multidisciplinary insight into clonal expansion of HTLV-1–infected cells in adult T-cell leukemia via modeling by deterministic finite automata coupled with high-throughput sequencing , 2017, BMC Medical Genomics.